✦ LIBER ✦

The adjuvant CLDC increases protection of a herpes simplex type 2 glycoprotein D vaccine in guinea pigs

✍ Scribed by David I. Bernstein; Nicholas Farley; Fernando J. Bravo; Julie Earwood; Monica McNeal; Jeff Fairman; Rhonda Cardin

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of herpes simplex virus type 2 g

✍ David I. Bernstein; Julie D. Earwood; Fernando J. Bravo; Gary H. Cohen; Roselyn 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 633 KB

Evaluation of AD472, a live attenuated r

✍ Mark N. Prichard; Ravi Kaiwar; Winthrop T. Jackman; Debra C. Quenelle; Deborah J 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 173 KB

Effect of an immune enhancer, GPI-0100,

✍ Debra C. Quenelle; Deborah J. Collins; Terri L. Rice; Mark N. Prichard; Dante J. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 109 KB

A Vaxfectin®-adjuvanted HSV-2 plasmid DN

✍ Ronald L. Veselenak; Mark Shlapobersky; Richard B. Pyles; Qun Wei; Sean M. Sulli 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 394 KB

The efficacy of a DNA vaccine encoding h

✍ T. D. Frye; H. C. Chiou; B. E. Hull; N. J. Bigley 📂 Article 📅 2002 🏛 Springer Vienna 🌐 English ⚖ 139 KB

A vaccinia virus — herpes simplex virus

✍ M Fleck; J. Podlech; K. Weise; D. Falke 📂 Article 📅 1994 🏛 Springer-Verlag 🌐 English ⚖ 428 KB